43 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
and the expected life of the award.
Employee benefits
The Company is required by Israeli law to make severance payments to Israeli employees upon … . A defined contribution plan is a program that benefits an employee after termination of employment, under which the Company regularly makes fixed payments
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
of interest, expected dividend yield, expected volatility and the expected life of the award.
Employee benefits
The Company is required by Israeli law … a number of post-employment defined contribution plans. A defined contribution plan is a program that benefits an employee after termination of employment
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
) other employee benefits, including share option agreements under any equity plan of the Company.
(y) Sarbanes Oxley Compliance. The Company … in the ordinary course of business pursuant to any employee or director option or benefits plan, stock ownership plan or dividend reinvestment plan
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
and $303,000 in amounts set aside or accrued to provide pension, severance, education fund, retirement, annual leave and recuperation or similar benefits … or expenses, commonly provided by Israeli companies to their employees (the “Benefits”). These aggregated amounts were allocated to the Covered
6-K
EX-99.1
ce415aun7jr4u0wj0xzp
12 Sep 22
Report of Foreign Private Issuer
8:02am
6-K
EX-99.3
u3japx
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
b636xj72m
6 Jul 22
Current report (foreign)
8:41am
6-K
EX-99.1
z8yeh3v2ka bhf3
6 Jun 22
Report of Foreign Private Issuer
8:03am
6-K
EX-99.1
hrcu02ma88z fou9l3uf
31 May 22
Report of Foreign Private Issuer
8:04am
6-K
EX-1.1
yuzfynihg7r4aczhujm8
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
omegm37q3wt g9w1h
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-99.1
fd7hy
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
147rb
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
86nt9w
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
31nc1iv s7
23 Jan 20
Annual report (foreign) (amended)
4:31pm